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Abstract
Background: There is a need to find innovative approaches for translating best practices for chronic disease care
into daily primary care practice routines. Primary care plays a crucial role in the prevention and management of
cardiovascular disease. There is, however, a substantive care gap, and many challenges exist in implementing
evidence-based care. The Improved Delivery of Cardiovascular Care (IDOCC) project is a pragmatic trial designed to
improve the delivery of evidence-based care for the prevention and management of cardiovascular disease in
primary care practices using practice outreach facilitation.
Methods: The IDOCC project is a stepped-wedge cluster randomized control trial in which Practice Outreach
Facilitators work with primary care practices to improve cardiovascular disease prevention and management for
patients at highest risk. Primary care practices in a large health region in Eastern Ontario, Canada, were eligible to
participate. The intervention consists of regular monthly meetings with the Practice Outreach Facilitator over a
one- to two-year period. Starting with audit and feedback, consensus building, and goal setting, the practices are
supported in changing practice behavior by incorporating chronic care model elements. These elements include
(a) evidence-based decision support for providers, (b) delivery system redesign for practices, (c) enhanced self-
management support tools provided to practices to help them engage patients, and (d) increased community
resource linkages for practices to enhance referral of patients. The primary outcome is a composite score measured
at the level of the patient to represent each practice’s adherence to evidence-based guidelines for cardiovascular
care. Qualitative analysis of the Practice Outreach Facilitators’ written narratives of their ongoing practice
interactions will be done. These textual analyses will add further insight into understanding critical factors
impacting project implementation.
Discussion: This pragmatic, stepped-wedge randomized controlled trial with both quantitative and process
evaluations demonstrates innovative methods of implementing large-scale quality improvement and evidence-
based approaches to care delivery. This is the first Canadian study to examine the impact of a large-scale
multifaceted cardiovascular quality-improvement program in primary care. It is anticipated that through the
evaluation of IDOCC, we will demonstrate an effective, practical, and sustainable means of improving the
cardiovascular health of patients across Canada.
Trial Registration: ClinicalTrials.gov: NCT00574808
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The impact of cardiovascular disease (CVD) can be
reduced by addressing key risk factors including smok-
ing, obesity, and hypertension [1-3]. Primary care is cen-
tral to the prevention and management of CVD. Ninety-
five percent of Canadians with chronic disease have a
regular family physician [4,5]. A majority of people per-
ceive their primary care providers as a credible resource
for health information and value their advice [6,7]. Pri-
mary care visits provide a unique opportunity to moni-
tor patients’ cardiovascular health and to initiate lifestyle
changes and preventive care [8-10]. Unfortunately, most
primary care practices are still transitioning from
approaches that are designed to treat acute illnesses and
are struggling to engage in high-quality management of
chronic conditions such as CVD [11-13]. There exist
significant care gaps, with recent studies showing that
less than half of patients with diabetes have optimal
blood glucose levels [14], and only 20% of patients with
dyslipidemia are being actively treated [15]. In addition,
despite the fact that smokers are two to four times
more likely to develop coronary heart disease [16], a
2005 report released by the Canadian Tobacco Use
Monitoring Survey indicated that only 54% of smokers
who visited a healthcare provider in the study year
received smoking cessation advice [17].
The Improved Delivery of Cardiovascular Care
(IDOCC) through Outreach Facilitation project aims to
improve the delivery of evidence-based care for the pre-
vention and management of CVD in primary care prac-
tices through the use of practice outreach facilitation.
The project is a multifaceted practice-tailored interven-
tion that includes (a) audit and feedback and goal set-
ting, (b) decision support for providers through the
integration of an evidence-based cardiovascular care
guideline, (c) practice delivery system redesign, (d)
enhanced linkages to community resources for patients,
and (e) patient self-management support tools. The
intervention is delivered by a Practice Outreach Facilita-
tor who helps incorporate these elements into daily
practice routines, thus assisting physicians and staff in
improving their delivery of evidence-based care for the
prevention and management of cardiovascular condi-
tions such as coronary heart disease, stroke/transient
ischemic attack (TIA), peripheral vascular disease, renal
failure, and diabetes. This innovative primary care qual-
ity-improvement trial is aligned with the chronic care
model (Figure 1) and key findings from a recent sys-
tematic review by the Cochrane Effective Practice and
Organization of Care (EPOC) Group on changing prac-
tice behavior [18]. In order to initiate positive, sustain-
able changes in practice behavior to improve chronic
disease care, interventions should (a) be multifaceted
[19], (b) be practice-tailored [20], and (c) involve
system-level changes based on the elements of the
chronic care model (Figure 1) [21].
Several other facilitation studies have looked at cardio-
vascular care [22-26], but none of these investigations
have examined the impact of facilitation and its sustain-
ability at the same depth and breadth as has the IDOCC
project. Although proven to be efficacious in improving
preventive care delivery in other areas of medicine, the
generalizability of facilitation in a Canadian healthcare
setting still remains unclear, as all investigations con-
ducted to date have taken place in highly controlled
small-scale settings, with the interventions being focused
on a select group of primary care models in either
urban or rural areas [27-31]. IDOCC is the first Cana-
dian study, and one of the first studies worldwide, to
examine the effectiveness of facilitation on cardiovascu-
lar care in a real life setting using a pragmatic design.
The primary research question in IDOCC is as fol-
lows: Does the large-scale implementation of a quality-
improvement intervention in cardiovascular care impact
(a) practice adherence to evidence-based cardiovascular
care guidelines and (b) patient clinical outcomes.
This article outlines the research methods used in the
IDOCC project. Unique features include the use of the
stepped-wedge design, mixed methods, and the incor-
poration of the chronic care model approach. We hope
to demonstrate that the use of practice outreach facilita-
tion, grounded in the chronic care approach, can be
successfully translated into different Canadian primary
Figure 1 The chronic care model, as described by Wagner et
al, [13]identifies six essential elements for appropriate care of
people with chronic diseases: 1) community linkages, 2) health
care organization, 3) delivery system redesign, 4) clinical information
systems, 5) decision support, and 6) self-management support for
patients. Taken collectively, these six elements are intended to
produce effective interactions between proactive prepared practice
teams and informed activated patients who take an active part in
their care. (Image from http://www.improvingchroniccare.org).
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able means of improving cardiovascular health.
Methods/design
Overview
IDOCC is a stepped-wedge cluster randomized control
trial where Practice Outreach Facilitators work with pri-
mary care practices to optimize CVD prevention and
management in those patients at high risk. The multifa-
ceted intervention, based on the chronic care model, is
being offered over a 24-month period. The primary out-
come is a composite score measured at the level of the
patient to represent each practice’s adherence to evi-
dence-based guidelines for CVD care.
Design
This cluster randomized control trial employs a stepped-
wedge design. A stepped-wedge design is a type of cross-
over study in which clusters cross over from the control
arm to the intervention arm at different time points [32].
The IDOCC program is being offered to practices ran-
domly assigned by region to one of three distinct steps
(26-30 practices per step), with each consecutive step (or
cohort of practices) beginning the program
approximately one year apart. The intervention is deliv-
ered to practices over a two-year period (Figure 2):
1. Year 1 - Intensive Phase: Practices receive Outreach
Facilitator visits every three to four weeks.
2. Year 2 - Sustainability Phase: Project intensity is les-
sened, with Facilitator visits every 6 to 12 weeks.
At the end of Year 2, a follow-up patient medical chart
audit is used to examine changes in adherence to guide-
lines and patient clinical outcomes between baseline and
Year 1 and baseline and Year 2 of the intervention (see
section on Project Outcomes). The time offset in the roll-
out of the intervention allows us to control for secular
changes over time as subsequent steps act as a control for
previous steps. For example, when examining the impact
of the intensive phase of the intervention, Step II practices
will serve as controls for Step I practices, and Step III
practices will serve as controls for Step II practices (Figure
2). Specific comparisons of interest in this project along
with their temporal controls are presented in Table 1.
Table 2 presents the progress of the IDOCC project.
Study setting
The project is set in primary care practices in the
Champlain Local Health Integration Network (LHIN)
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aBaseline-A: data collected pre-intervention for the purposes of the audit and feedback component of the IDOCC intervention;
 
bBaseline-C: data collected post-intervention––these data are required in order to allow for a controlled before-and-after analysis
of the intervention. 
Shaded cells represent intervention periods 
Blank cells represent control periods 
 
Control for Step I (Intensive Phase) 
Control for Step II (Intensive Phase) 
Control for two-year IDOCC project for 
Step I 
Figure 2 IDOCC Step-wedge study design.
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LHIN is a culturally diverse region with a population of
1.2 million people who have chronic disease burdens
and patient health outcomes that are comparable to
Ontario and the rest of Canada [33]. Excluding walk-in
clinics, all models of primary care practices in the
selected geographic areas of the Champlain LHIN are
eligible to participate in this project, including solo prac-
tices, group practices, community health centers, and
academic health center teaching practices.
The Champlain LHIN was first divided into nine geo-
graphic regions using Geographic Information System
mapping technology [34] and then the regions were
grouped together into strata by their location (i.e., west,
central, and east) (Figure 3). Next, a computer-generated
randomization assigned each region within each stratum
into one of the three steps. Randomization at the regio-
nal level was done (a) to ensure that each step was com-
prised of one region from each stratum (east, central,
and west), (b) to ensure that each region per stratum
had the same probability of being in any given step and
t h u st h es a m ep r o b a b i l i t yo fb e g i n n i n gt h ei n t e r v e n t i o n
at any given time point, and (c) because practice-level
randomization was logistically impractical for traveling
between practices randomly scattered throughout this
large health region (16,000 sq. km). Using provincial
administrative data, practice-level (i.e., practice model
type, rurality, average physician age, gender mix) and
patient-level (i.e., age, sex, socioeconomic status, number
of comorbidities) characteristics of practices that con-
sented to take part in IDOCC will be compared across
the nine regions and across the three steps to assess any
nonandomness of the randomization process, as well as
across all practices and patients in Ontario to assess
provincial representativeness.
Practice recruitment
Prior to the initiation of the recruitment process for
each step, we developed an up-to-date list of the contact
information of all physicians practicing in the geo-
graphic regions of interest using a variety of physician
listings, such as The College of Physicians and Surgeons
of Ontario website, the yellow pages, the provincial
directory of group practices and through direct contact
with the practices. Practice recruitment was carried out
using a modified Dillman approach involving reminders
and repeat mailings [35]. While no compensation was
offered to practices for participation, a pre/post-inter-
vention chart audit measuring the quality of their prac-
tice’s overall cardiovascular care and the opportunity to
obtain continuing professional development credits
upon completion of the program (15 Mainpro-C credits,
Table 1 IDOCC study comparisons
Phase Step Change in outcome Temporal/societal control
Intensive I XSI, T2 -X SI, T1 XSII, T2 -X SII, T1
II XSII, T3 -X SII, T2 XSIII, T3 -X SIII, T2
Sustainability I XSI, T3 -X SI, T2 XSIII, T3 -X SIII, T2
II XSII, T4 -X SII, T3 ——
Overall study I XSI, T3 -X SI, T1 XSIII, T3 -X SIII, T1
SI = Step I, SII = Step II, SIII = Step III, T1 = Time Period 1, T2 = Time Period 2,
T3 = Time Period 3, X = a quality-of-care outcome or a patient clinical
outcome.
Note: There is no control for the Step II sustainability phase
Table 2 Study design and progress of IDOCC program participation of practices and physicians as of April 2011
IDOCC program
Study Design Intensive phase Sustainability phase Final data collection
Step I - First cohort of practices
(26 practices, 59 physicians)
Start: April 2008 April 2009 July 2010
Completed as of April 2011: 26 practices, 59 physicians 26 practices, 59 physicians 26 practices, 59 physicians
Projected completion: January 2010
(Complete)
January 2011
(Complete)
February 2011
(Complete)
Step II - Second cohort of practices
(30 practices, 79 physicians)
Start: April 2009 April 2010 October 2011
Completed as of April 2011: 30 practices, 79 physicians 1 practice, 2 physicians –
Projected completion: March 2011
(Complete)
March 2012 September 2012
Step III - Third cohort of practices
(27 practices, 53 physicians)
Start: January 2010 January 2011 July 2012
Completed as of April 2011: 13 practices, 25 physicians ––
Projected completion: June 2011 June 2012 June 2013
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tives. Practices were enlisted into the IDOCC program if
at least one physician from that practice agreed to parti-
cipate in the project. Practices agreeing to take part in
the project were asked to fill out a practice-characteris-
tic survey highlighting details about their practice,
including number of patients for the physician, primary
care model type, years in practice, etc. The consent
signed by each physician allowed the project team to
collect information from their patient medical charts
and to link this information to the province’sh e a l t h
administrative databases. Practices entered the project
immediately after consenting to the project. We also
completed nonparticipant surveys for the practices that
Figure 3 Geographic breakdown of the Champlain LHIN.
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t h es u r v e yi st oi d e n t i f yr e a s o n sf o rn o tw a n t i n gt op a r -
ticipate and collect data on practice characteristics so
that we could assess participant selection bias.
Target patient population for quality improvement
The aim of the IDOCC project is to improve the quality
of care delivered to those patients with and at high risk
of CVD. This includes patients being over 40 years of
age with at least one of the following four criteria: (1)
CVD including coronary artery disease, cerebrovascular
disease (documented stroke and/or TIA), or peripheral
vascular disease; (2) diabetes mellitus; (3) chronic kidney
disease; and/or (4) be at high risk for CVD based on the
presence of at least three of the following cardiovascular
risk factors: age (males ≥ 45, females ≥ 55), smoker,
hypertension, and dyslipidemia [36].
Components of the IDOCC project
Key components of the IDOCC project include using
the Outreach Facilitator to deliver elements of the
chronic care model to each practice (the healthcare
organization of interest). The practice outreach facilita-
tion approach includes audit and feedback, consensus
building, regular meetings (monthly to quarterly) with
the practices, and interactive collaborative meetings:
a) Practice outreach facilitation: Four health profes-
sionals with master’s degrees and clinical and manage-
rial experience are employed as Practice Outreach
Facilitators and work with 10-15 practices each. All had
previous primary care experience and underwent a
seven-week intensive training course focused on quality
improvement and change-management techniques, the
chronic care model, and system tools for cardiovascular
care, including the evidence-based guideline used by the
IDOCC project http://www.idocc.ca. This training pro-
vided them with the knowledge base and hands-on
training required to effectively support healthcare provi-
ders in implementing changes to their practices.
i) Audit and feedback: The chart audits are com-
pleted by trained chart abstractors who randomly
select 66 target-population patient charts per prac-
tice to assess the pre-intervention performance of
each practice [37]. Information is collected regarding
disease/risk factor screening, prescribing, community
and self-management support referrals (e.g., referral
to smoking cessation programs), and clinical out-
comes for patient groups (e.g., blood pressure mea-
sures, hemoglobin A1c results). The Outreach
Facilitator presents these chart audit results to all
primary care providers and relevant office staff in
the practice during a 30-60 minute meeting using a
Microsoft PowerPoint (Microsoft Corporation,
Redmond, WA, USA) presentation. The practice’s
performance is compared to the average perfor-
mance across all IDOCC project participants and
published regional numbers in order to highlight
both areas of high-quality care and potential areas
for improvement.
ii) Consensus building and regular meetings: The
Outreach Facilitator then works with the primary
care providers and relevant office staff to help them
identify opportunities for improvement and select
appropriate strategies to address these opportunities
by incorporating a chronic care model approach.
Goal setting, planning, and implementation are
based on the Plan Do Study Act cycle, which is a
common quality-improvement tool [38]. The Out-
reach Facilitators regularly meet with healthcare pro-
viders over the two-year intervention period to
support practices in implementing system-level
changes to achieve their goals. The Outreach Facili-
tator supports health providers in initiating, sustain-
ing, and measuring changes to their practice but
does not take the lead in implementing these
changes. Members of the practice work towards the
changes they selected under the guidance and sup-
port of the Outreach Facilitator. The support
includes both aiding with implementing changes and
helping practices determine roles for interested team
members.
Outreach Facilitators regularly meet with practice
members to support change implementation and to
build a trusting relationship. Relationship building has
been cited as an important aspect of the facilitation pro-
cess and is based on continuity of contact and the per-
sonalities of the practices and the Outreach Facilitators.
Physicians participating in a past facilitation study cited
the necessity of Outreach Facilitators to be available,
knowledgeable, and encouraging of new ideas and invol-
ving all practitioners [39].
iii) Interactive collaborative meetings: A series of
cardiovascular-care-themed half-day collaborative
meetings for IDOCC participants are being held in
different locations within the region. These meetings
are designed to be highly interactive, as they involve
group brainstorming sessions, breakout group dis-
cussions, and participants sharing experiences and
approaches implemented in their practices. Topics
are determined based on requests from participating
physicians and, to date, have included addressing
challenges in engaging patients in self-management,
connecting with local pharmacists and other com-
munity resources available to patients, and diabetes
care. Closely linked to the meetings are knowledge
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areas for quality improvement. Newsletter topics
have included smoking cessation strategies, hyper-
tension, self-management support, and diabetes care
(see http://www.idocc.ca).
b) Chronic care model: The quality improvement
approach is grounded in key elements of the chronic care
model (Figure 1) in order to facilitate rapid knowledge
translation and practice-level changes. Outreach Facilita-
tors focused on the following four elements: (1) evidence-
based decision support for providers, (2) delivery system
redesign for practices, (3) enhanced self-management sup-
port tools provided to practices to help them engage
patients, and (4) increased community resource linkages
for practices to enhance referral of patients. We are not
specifically focusing on clinical information systems, as the
majority of the practices in our health region are still
paper based. The Outreach Facilitator will, however, sup-
port development and optimization of clinical information
systems when identified as a need by the practice.
i) Decision support: Decision support is guided pri-
marily by the use of an integrated CVD care guideline:
The Champlain Primary Care CVD Prevention and
Management Guideline http://www.idocc.ca. The goal
of the Guideline is to harmonize the management and
target outcomes for multiple vascular conditions (cor-
onary artery disease, TIA/stroke, diabetes, renal failure,
and peripheral vascular disease), summarize evidence-
based strategies for the detection and management of
these vascular conditions and their associated risk fac-
tors (high blood pressure, high cholesterol, smoking,
physical inactivity, and obesity), and maximize the use
of local resources and tools in the provision of care.
The Guideline is a very valuable tool, as most primary
care physicians struggled to follow multiple, some-
times conflicting guidelines for each individual cardio-
vascular condition or risk factor [10,40]. The
Champlain CVD Prevention and Management Guide-
line is the first Canadian guideline for primary care
that includes standardized care pathways for patients
with multiple chronic disease and cardiovascular risk
factors. It was developed based on the recommenda-
tions of seven Evidence Monitoring Committees estab-
lished for each of the seven risk factors targeted by the
IDOCC project: hypertension, dyslipidemia, diabetes,
chronic kidney disease, smoking, obesity, and physical
inactivity [41].
Upon enrollment, all practices are provided with a
paper copy of the Champlain CVD Guideline in binder
format and directed to the IDOCC website http://www.
idocc.ca for an annually updated online version of the
Guideline. At the initiation of the intervention, each
Facilitator provides an overview of the Guideline to each
practice team, highlighting the development, organiza-
tion, and strengths of the Guideline. In subsequent visits,
the Facilitator commonly refers back to the Guideline in
order to stress specific evidence-based practices or to
point out clinical targets and community resources.
ii) Community resources: A key feature of the Cham-
plain CVD Prevention and Management Guideline is
the community resource section in which all pro-
grams relevant to cardiovascular care for a given con-
dition or risk factor are listed. For example, current
community smoking cessation programs and exercise
programs are listed with referral information specific
to each region–this information is kept up to date by
both the work of the Facilitators and linkages estab-
lished within the Champlain CVD Prevention Net-
work. An annual update is done on the online version
of the Guideline. In cases where practices require
additional information from community resources,
Facilitators act as liaisons, connecting directly with
education and community programs.
iii) Self-management support: Many practices are
interested in enhancing self-management support
within their practices. Tailored plans that are prac-
tice specific are developed to support these practices
using various approaches, such as incorporating goal
setting and action planning into patient visits. The
IDOCC project also developed an inventory of self-
management support tools such as pocket cards,
flow sheets, questionnaires, and patient self-manage-
ment action plan forms to help physicians improve
their delivery of evidence-based care. Tools can be
accessed at http://www.idocc.ca/en_toolkits.php.
iv) Delivery system redesign: In helping physicians
reach their goals, the Outreach Facilitators focus on
assisting practices set up new systems and processes to
help improve care delivery. Specific examples of
improvement strategies include the utilization of regis-
tries to track patients with certain conditions, recall
systems, reminder systems, and group visits for
patients with common conditions (e.g., several diabetes
patients come in at one time to have screening tests
performed and to learn about self-management).
These systems are implemented into practices using a
tailored approach based on practice needs and avail-
able resources. For example, some practices have elec-
tronic medical records (EMRs) that allow them to
filter their patient lists to create disease-specific regis-
tries and recall systems, while other practices that use
paper charts create Microsoft Excel (Microsoft Cor-
poration, Redmond, WA, USA) documents or cue
cards to track their high-risk patients.
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The primary source of data collection consists of
repeated chart audits [42] of the same randomly selected
patient population from each participating practice.
Chart Abstractors visit practices on two separate occa-
sions to collect chart data–once pre-intervention and
once postintervention.
Pre-intervention
B a s e l i n ed a t aw e r er e q u i r e dt op r o v i d ee a c hp r a c t i c e
with feedback on their pre-intervention performance
levels during the audit and feedback component of the
intervention (Figure 2: Baseline-A).
Post-intervention
After Year 2 of the intervention has ended in each prac-
tice, Chart Abstractors will return to collect medical
chart data from both intervention years (i.e., Year 1:
intensive phase, Year 2: sustainability phase) and to also
collect pre-intervention baseline control data (Figure 2:
Baseline-C). Participation in the follow-up data collec-
tion is encouraged through the following practices: (a)
practices sign a consent form stating that they will allow
a post-study follow-up, and (b) each practice is told that
they will receive an end-of-study progress report high-
lighting changes in patient health and adherence to evi-
dence-based guidelines.
Other data sources include Facilitator narrative
reports, which are essentially field notes recorded after
each practice encounter, including visits, email, and tele-
phone encounters.
Patient selection for medical chart abstraction
Patient medical charts are randomly selected using
established chart-sampling protocols utilized by the pro-
ject team in the past, including the “tape measure
method” for paper and mixed charting systems (i.e.,
paper and electronic records) and a random number
approach for electronic records [42].
Chart Abstractors are collecting cardiovascular-related
diagnostic and screening data, clinical test results, drug
prescription information, and notes regarding referrals to
specialists or programs. All Chart Abstractors are blinded
to the exact details of the intervention and are unaware
of the details of the composite score that will be analyzed
at the end of this study to reduce reporting bias.
This project, including its chart audit protocol, was
approved by both the Ottawa Hospital Research Ethics
Board and the Bruyère Continuing Care Research Ethics
Board. In accordance with the Tri-Council Policy State-
ment, individual patient consent was not required, since
(a) the project was targeted at changing physician prac-
tice behavior within established standards of care and
project staff did not work directly with the patients, (b)
IDOCC will examine and report only aggregate practice
population data, and (c) this project posed minimal risk
to the welfare and privacy of the patients [43].
Quality control
To ensure the consistency and quality of the abstracted
data across Chart Abstractors, a four-part quality-moni-
toring process was established, which includes (1) stan-
dardized protocol implementation, (2) extensive data
abstraction training, (3) continuous re-abstraction and
validation to monitor the interrater reliability between
Abstractors, and (4) constant feedback and retraining.
Our overall baseline interrater reliability kappa value was
0.91, and the overall percent agreement was 94.3% [37].
Narrative reports
Practice Outreach Facilitators are completing a narrative
summary in which they document facilitation activities
for each practice encounter, including face-to-face visits,
telephone calls, and emails. The narratives are struc-
tured based on the chronic care model and include both
long-term and short-term goals and related activities.
They also include details related to challenges and bar-
riers to change within the practice. Investigators meet
on a bimonthly basis to review a sample of the narra-
tives to monitor data quality.
Project outcomes
Composite scores are widely employed in cardiovascular
interventions targeting multiple care processes as they
not only reduce sample-size requirements but also pro-
vide an overall picture of interventional benefits and
group performance [44]. For this reason, a quality of
care (QOC) composite score was chosen as the primary
outcome for this project.
The QOC composite score reflects practice adherence
to recommended process-of-care maneuvers, as outlined
in the Champlain CVD Prevention and Management
Guideline. The maneuvers making up the composite
score are listed in Table 3 and were collected through
chart audits. The QOC composite score for this project
is measured at the patient level and can be summarized
by the following formula:
QOCcompositescore =

of recommended process − of − care indicators performed on patient

of recommended process − of − care indicators for which the patient was eligible
Secondary clinical outcomes
Clinical outcome data collected through the chart audit
will be used to determine the change in the proportion
of patients who were at target levels (as specified in the
Champlain CVD Prevention and Management
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Condition/risk factor List of indicators
Coronary artery disease ➢ Blood pressure checked in past 12 months?
➢ Fasting blood glucose taken in past 12 months?
➢ Lipid profile taken in past 12 months?
➢ Waist circumference measured in past 12 months?
➢ If waist circumference is above limits (male > 88 cm, female > 102 cm), was referral to a dietician or an exercise
program recommended or discussed?
➢ Was a cardiovascular disease medication (e.g., beta-blocker, ACE inhibitor) recommended/discussed/prescribed in the
past year?
➢ Was aspirin recommended/discussed/prescribed in the past year?
Chronic kidney disease ➢ Albumin/creatinine ratio checked in past 12 months?
➢ Blood pressure checked in past 12 months?
➢ Lipid profile taken in past 12 months?
➢ Estimated glomerular filtration rate taken in past 12 months?
Diabetes mellitus ➢ Blood pressure checked in past 12 months?
➢ Lipid profile taken in past 12 months?
➢ Was a glycemic control medication recommended/discussed/prescribed in past year?
➢ Hemoglobin A1c taken twice in past year?
➢ Waist circumference measured in past 12 months?
➢ If waist circumference is above limits (male > 88 cm, female > 102 cm), was referral to a dietician or an exercise
program recommended or discussed?
Peripheral vascular disease ➢ Blood pressure checked in past 12 months?
➢ Fasting blood glucose taken in past 12 months?
➢ Lipid profile taken in past 12 months?
➢ Was a lipid-lowering medication recommended/discussed/prescribed in the past year?
➢ Was an ACE inhibitor or angiotensin receptor blocker recommended/discussed/prescribed in the past year?
➢ Was aspirin recommended/discussed/prescribed in the past year?
➢ Waist circumference measured in past 12 months?
➢ If waist circumference is above limits (male > 88 cm, female > 102 cm), was referral to a dietician or an exercise
program recommended or discussed?
Stroke/transient ischemic
attack
➢ Blood pressure checked in past 12 months?
➢ Fasting blood glucose taken in past 12 months?
➢ Lipid profile taken in past 12 months?
➢ Was aspirin recommended/discussed/prescribed in the past year?
Dyslipidemia ➢ Lipid profile checked in past 12 months?
➢ Was a lipid-control medication recommended/discussed/prescribed in the past year?
➢ Waist circumference measured in past 12 months?
➢ If waist circumference is above limits (male > 88 cm, female > 102 cm), was referral to a dietician or an exercise
program recommended or discussed?
Hypertension ➢ Blood pressure checked at least three times in past year?
➢ Was a blood pressure control medication (e.g., beta-blocker, ACE inhibitor) recommended/discussed prescribed in the
past year?
➢ Waist circumference measured in past 12 months?
➢ If waist circumference is above limits (male > 88 cm, female > 102 cm), was referral to a dietician or an exercise
program recommended or discussed?
Smoking ➢ Was smoking status checked in the past year?
➢ If patient smokes, was there counselling or referral to a smoking cessation program?
➢ Was a smoking cessation drug (e.g., Nicotine patch, Champix, etc) recommended/discussed/prescribed in the past
year?
ACE: Angiotensin Converting Enzyme
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of the intervention.
Sample-size calculation
Prior to the recruitment phase of this project, a series of
simulations were run on patient data from a pilot phase
of the chart audit in order to examine how the primary
outcome composite score varied with specific changes in
physician adherence to recommended guidelines. For
example, if Patient X had diabetes and a composite score
of Y, how would Patient X’s composite score change if
he/she now had (a) a discussion about glycemic control
medications with his/her physician? (b) a lipid profile test
performed? (c) both maneuvers performed? The results
from each simulation were discussed amongst a panel of
family physicians and cardiologists in order to assess
what effect size or change in composite score would
represent a clinically relevant change in provider perfor-
mance. From these discussions, it was agreed that an
effect size (mean difference in the composite score for
practices in the intervention step vs. the comparison
step) of 8% represented a clinically relevant change.
Using the sample-size calculation formulas for comparing
two means presented by Donner and Klar [45], and
assuming an intra-cluster correlation coefficient (ICC) of
0.18, a common standard deviation of 18%, and an aver-
age of 66 charts per practice, we would require 21 prac-
tices per step to detect an 8% difference using a two-
sided test at the 5% level of significance with 90% power.
To account for 20% potential attrition, a total of 27 prac-
tices per step were enrolled. The ICC and standard devia-
tion used for this calculation were derived from the
IDOCC pilot project on nearly 500 patients across seven
practices. The anticipated attrition rate accounted for
both practice-level as well as patient-level attrition and
was based on experience from previous practice-based
research studies [27-29].
Data analysis
A mixed-methods approach will be used, which will
consist of analysis of both quantitative data and qualita-
tive data.
Quantitative analysis
Descriptive statistics will be generated for all project vari-
ables (means and standard deviations for continuous vari-
ables with normal distributions or medians and
interquartile ranges for skewed distributions, and frequen-
cies and proportions for categorical variables). These sta-
tistics will be compared among the practices allocated to
the different steps of the stepped-wedge design to assess
imbalances in practice characteristics that would need to
be controlled for in the analyses, including age, sex, prac-
tice model type, urban/rural practice setting, practice size,
patient socioeconomic status (determined using a census-
based method [46]), and patient comorbidities. Physicians
agreeing to participate in the project will be compared to
those declining to participate, and those characteristics
significantly associated with participation will be adjusted
for in secondary analyses to explore the potential impact
of participation bias on our results. All analyses will be
conducted using a commercially available software pack-
age (SAS, Version 9.2, SAS Institute, Inc., Cary, NC, USA
[47]) with a = 0.05 as the level of significance.
Although the practice is the unit of intervention, all
process and clinical measurements are at the patient
level, and as such, the patient is the unit of analysis. All
primary and secondary outcomes will be analyzed using
general linear mixed-effects regression models using the
stepped-wedge design analysis approach outlined by
Hussey and Hughes [48]. All models include random
effects for practice to account for the ICC of patients
within the same practice, as well as fixed effects for
region (the stratification used in the randomization
scheme).
Prespecified controlled comparisons (Table 1) among
practices in specific steps will be made in the regression
models to examine the impact of the intervention while
controlling for the effects of time. For example, in order
to estimate the impact of the intensive phase of the pro-
ject on Step I practices, a comparison of the patients in
the intervention (Step I) and control (Step II) groups
will be done by comparing the mean changes in the pri-
mary (i.e., QOC composite score) and secondary out-
comes from baseline (Time Period 1) to the intensive
phase year (Time Period 2) (Table 1).
In addition, since we are serving such a diverse group
of patients with varying comorbidities, the number of
indicators for which each patient is eligible varies; thus,
certain patients may have a greater impact on statistical
estimates of the primary outcome composite score than
others. For example, if Patient A was eligible for 4 man-
euvers and Patient B was eligible for 8, a change in one
maneuver for Patient A results in a 0.25 change in the
composite score, while the same change for Patient B
only results in a change of 0.13. A “performance indica-
tor eligibility” covariate will be included in the regres-
sion model in order to account for the differences in the
number of performance indicators for which each
patient was eligible.
A backwards stepwise approach will be used to estab-
lish regression models in which only variables significant
at the a < 0.1 level remain.
Qualitative analysis–Practice Outreach Facilitator
narratives
Descriptive analysis will be used to report information
on the types, frequency, and intensity of the Outreach
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for analysis by entering Outreach Facilitator narratives
and descriptive practice profiles into the NVivo 8 soft-
ware program (QSR International, Cambridge, MA,
USA). The data analysis team members will include the
clinician investigators and members of the research staff
trained in qualitative research.
The analysis of the data will follow standard qualita-
tive techniques of constant comparison and immersion
crystallization [49].
We will particularly explore how narratives vary
between Outreach Facilitators to understand the meth-
ods they employ and investigate the degree of variation
in approaches between Facilitators. We will focus on
communication methods, frequency of visits, and tools
used. The research staff will read and summarize the full
transcripts for each practice. For the purpose of this
study, we will consider each Outreach Facilitator as a
separate case, with the individual practices that each
Facilitator works with acting as an embedded unit of ana-
lysis. The qualitative research staff will read and reread
the practice summaries and present a proposed cross-
case thematic analysis to the larger analysis team includ-
ing the clinical investigators for discussion. Further ana-
lyses will characterize typologies for the Outreach
Facilitator roles and routines. These will be defined, dis-
cussed, and re-explored in an iterative process. Cross-
case analysis will be employed to compare and contrast
Outreach Facilitator methods, and these data will be tri-
angulated with the larger datasets to determine if any of
the above factors (communication methods, etc.) influ-
ence the practice’s strategies for change.
Discussion
We have described the methods for implementing a
large-scale pragmatic trial in primary care. To our
knowledge, the IDOCC project is the largest practice
outreach facilitation trial in Canada to date. It builds on
previous research in practice facilitation and attempts to
translate research evidence into practice in the impor-
tant area of CVD management. The use of a stepped-
wedge design to evaluate this type of quality-improve-
ment trial is novel [28,32]. The most frequent complaint
made by physicians and policy makers in regards to
small-scale randomized control trials and systematic
reviews is that they lack widespread applicability and
thus provide insufficient information to make informed
decisions about translating research into practice
[50,51]. For this reason, many decision makers have
made a call for greater applicability in healthcare
research and an increase in the implementation of “real-
life” pragmatic trials [51,52].
Our real-life pragmatic study is designed so that the
project can be delivered to all practice structures and
primary care organizational model types. Furthermore,
unlike other cardiovascular facilitation studies that have
simply evaluated their interventions using self-adminis-
tered questionnaires [22-25], we use a mixed-methods
approach and are collecting both process implementa-
tion data and practice care delivery and patient clinical
outcome data through a rigorous, stepped-wedge design.
The stepped-wedge design is ideal in such a large-scale
implementation project as it has the following advan-
tages: (a) it helps overcome the practical, logistical, and
financial constraints associated with large-scale project
implementation; (b) it allows us to control for the effect
of time as data from the intervention periods could be
compared to data from the control periods of the
wedge; and (c) it ensures that all practices in the project
are offered the intervention [32].
Changing practice behavior requires an internal orga-
nizational change of operations best achieved through a
process that integrates staff roles and responsibilities in
a practice-individualized manner [18,53-56]. Practice
outreach facilitation is one such method of assisting the
practices to optimize care delivery. Although the effec-
tiveness of practice outreach facilitation has been
demonstrated in several randomized controlled trials
[57-59] and the cost effectiveness has been proven in
one trial [60], funding due to human resource costs
associated with practice outreach facilitation can be
challenging. The sequential rollout and also the eventual
inclusion of all interested practices helped to overcome
these constraints, especially in discussions with decision
and policy makers. We were able to fund this project,
one step at a time, through multiple partnerships with
decision makers, policy makers, industry, and traditional
health research funders.
Finally, IDOCC is a quality-improvement trial that is
geared towards a group of related diseases, as opposed
to targeting a single disease. The majority of people are
affected by multiple chronic illnesses and do not identify
themselves according to the disease, neither do their
doctors [61]. By targeting improvements in CVD as a
whole, we are addressing the complexity of caring for
patients with multiple chronic illnesses in the primary
care setting.
Limitations
The greatest concern of all voluntary quality-improve-
ment interventions, including practice facilitation, is the
issue of participation bias and the idea that the physi-
cians and practices that need help the most are the least
likely to participate in quality-improvement interven-
tions. Although it is likely that we have participation
bias, we know from baseline data that a significant care
gap did exist within our participating practices. We will
quantify the potential participation bias within our
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questionnaires (e.g., physician gender, graduation year,
primary care model) to compare participants versus
nonparticipants to elucidate specific practice and physi-
cian characteristics that may be attributable to self-
selection into this project. We also plan on linking to
administrative databases to compare the baseline perfor-
mance and patient characteristics (e.g., sociodemo-
graphic characteristics of patient population, patient
comorbidities using the Charlson Comorbidity Index,
number of hospitalizations, drug prescription patterns)
of practices participating in the project to regional
averages to see if there is a significant difference
between the two. The above steps will provide insight
into potential self-selection biases and the overall gener-
alizability of our findings.
The issue of assigning weighting factors to the indica-
tors in this project was also extensively discussed by the
p r o j e c tt e a m .W eh a dc o n s i d e r e da s s i g n i n gs p e c i f i c
weights to each indicator in order to reflect their rela-
tive importance to patient health outcomes. Unfortu-
nately, there is no empirical evidence for assigning
weighting factors to the indicators in this project.
Although theoretically useful, many authors have
acknowledged the difficulty in effectively determining
meaningful weights, and as such, few researchers use
this approach [44]. Moreover, all statisticians and
experts that were consulted about the primary outcome
f o rt h i sp r o j e c ta d v i s e du st om o v ef o r w a r dw i t ht h e
nonweighted score, as they agreed that weighted end-
points should be avoided when there is no clear evi-
dence available to assign specific weights. In order to
help avoid the problems associated with misinterpreting
equally weighted endpoints, we will report the results of
all components of the composite score independently to
allow readers to get a clear picture of the overall impact
of the intervention.
Another limitation of this study is that the timing of
the intervention was randomly assigned at the regional
level. A more powerful approach would have been to
have random assignment at the practice level. Although
ideal, practice-level randomization was logistically
impractical for a project of this size, as traveling between
different practices that are randomly scattered through-
out this large health region (16,000 sq. km) would have
greatly increased project costs and extended project time-
lines. By having practices grouped into regions, Outreach
Facilitators and Chart Abstractors were able to visit mul-
tiple practices within a given day, something that would
be difficult in a practice-randomized study.
Finally, we acknowledge the limitations of using medi-
cal chart data. Studies have demonstrated that direct
observation can often identify more details about care
delivery than chart audits; however, none of these studies
have quantified how big this gap is [62,63]. As such, it is
likely that we will underestimate the number of proce-
dures carried out. However, numerous studies have
demonstrated that chart review is the gold standard for
collecting medical data as direct observation is prohibi-
tively expensive and not feasible for a trial this large and
administrative data are generally less reliable than chart
data [63]. This discrepancy will affect our generalizability
when we talk about the regional adherence to the Guide-
lines, but it should not affect the evaluation of our inter-
vention as the same limitation applies to the data
collected in all steps and all time periods.
Implications of this research
The goal of the IDOCC intervention is to improve car-
diovascular care and patient health outcomes. This pro-
ject was designed to align with the chronic care model
and is being delivered on a large scale to a diverse
group of practice models in a real-life setting. A prag-
matic, stepped- wedge design with both quantitative and
process evaluations will contribute to the evidence base
related to quality improvement, guideline dissemination,
and cardiovascular care. The results of this pragmatic
trial will inform decision makers about methods of
implementing large-scale quality improvement and evi-
dence-based approaches to care delivery. It is anticipated
t h a tt h r o u g ht h eI D O C Cp r o j e c t ,w ew i l lb ea b l et o
demonstrate an effective, sustainable means of improv-
ing the cardiovascular health of Canadians.
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